Replies to post #217608 on Kraig Biocraft Laboratories Inc (KBLB)

[jealmc79]

“KBLB & Maxim will set the price of the offering, but they have to make it lower than the post-r/s price, or no one will buy it.”

No they don’t. They are getting the stock and a warrant. If you were to offer me a stock and a warrant for the current price of the stock I would take it in a heartbeat. In fact, I just might.

[rayovac812]

I know all of this is assumptions & possibilities.

As well as a zero sum projection. It won't be. News will accompany the uplist/RS/financing. That is what KBLB has been saying for quite some time.

KBLB has always been driven by the news. We just have not directly been getting the news people want to hear. This is very deliberate, just as deliberate as when the news is what we want to hear.

The fundamentals will have to be obviously good. Things are rarely as good or bad as they seem. Especially when the share price is making short term moves.

[Deannie]

The whole point of going to Nasdaq is to be exposed to and considered by the MM’s of the world. My belief is that in the big picture, whatever the dilution turns out to be, 8,10,12%+, it’s relatively small potatoes and out of our control. In a stock as risky as KBLB, I'm not looking for a 30%-50% return that would be significantly impacted by the pending dilution. I’m looking for doubling to 3x, 5x or even 10x+ in the coming months. Again, this is a high risk stock and one should be in it for a commensurate return - that’s why I only invested (or risked depending on how you look at it) a few percent of my portfolio in KBLB. If one’s goal is 10%-20%, let me recommend Microsoft or Apple. Having said that, The IP and superior product most of hope will soon be verified as being produced in commercial quantities should make this a $ billion+ company which would represent big multiples, if not right away, certainly in the short to medium term. If one is extremely concerned about the dilution, then sell. If not, then hang on as it could be one helluva ride.